Jeffrey R. Burton

TL;DR: Coronary stenting with abciximab, compared with stenting alone or balloon angioplasty with ab ciximabs, is associated with improved survival and is an economically attractive therapy by conventional standards.

TL;DR: Simvastatin patients had less need for percutaneous transluminal coronary angioplasty, and fewer enalapril patients experienced the combined end point of death/myocardial infarction/stroke than their respective placebo patients, extending the observation of the beneficial angiographic effects of lipid-lowering therapy to normocholesterolemic patients.

TL;DR: There was no difference between the VEGF-treated and the placebo groups in the primary end point of change in myocardial perfusion from baseline to 3 or 6 months, assessed by single photon emission tomography (SPECT) imaging, although a significant reduction in the ischemic area was seen in both groups.

TL;DR: Women do not differ significantly from men with regard to either early infarct-related artery patency rates or reocclusion after thrombolytic therapy or ventricular functional response to injury/reperfusion, and gender was an independent determinant of 30-day mortality.

TL;DR: The effect of late percutaneous transluminal coronary angioplasty of an occluded infarct-related artery on left ventricular ejection fraction was studied in patients with a recent, first Q-wave myocardial infarction in a prospective, randomized study.